Holen Sie sich die Stockscreener-App
11.07
1.42%
-0.16
Handel nachbörslich:
11.23
0.16
+1.45%
Avadel Pharmaceuticals Plc Aktie (AVDL) Neueste Nachrichten
Avadel Pharmaceuticals plc Stock Analysis and ForecastOverwhelming profit margins - jammulinksnews.com
Is Avadel Pharmaceuticals plc a good long term investmentHigh-yield capital appreciation - jammulinksnews.com
What analysts say about Avadel Pharmaceuticals plc stockSuperior investment outcomes - Autocar Professional
Insider Stock Buying Reaches US$761.7k On Avadel Pharmaceuticals - simplywall.st
Avadel Pharmaceuticals Plc (NASDAQ:AVDL) Has Found A Path To Profitability - 富途牛牛
Avadel Pharmaceuticals (NASDAQ:AVDL) Now Covered by HC Wainwright - MarketBeat
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Teacher Retirement System of Texas Lowers Holdings in Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals (NASDAQ:AVDL) Upgraded at HC Wainwright - Defense World
Avadel Pharmaceuticals (NASDAQ:AVDL) Research Coverage Started at HC Wainwright - Defense World
Avadel Stock Climbs as Appeals Court Backs FDA Approval of LUMRYZ - MSN
HC Wainwright Initiates Buy Rating on Avadel Pharmaceuticals with $22 Price Target - AInvest
What drives Avadel Pharmaceuticals plc stock priceRobust investment performance - jammulinksnews.com
Avadel Pharmaceuticals: HC Wainwright assumes Buy, PT at $22. - AInvest
How Avadel Pharmaceuticals plc stock performs during market volatilityStrategic High Profit Opportunities - beatles.ru
Why Avadel Pharmaceuticals plc stock attracts strong analyst attentionDaily Gain Forecast - Newser
What makes Avadel Pharmaceuticals plc stock price move sharplyConsistent Growth Alert - Newser
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Given Average Rating of “Buy” by Analysts - Defense World
ASL Strategic Value Fund Files an Exempt Solicitation Statement with Securities and Exchange Commission - MarketScreener
ASL Strategic Value Fund Issues Open Letter to Avadel Shareholders - Business Wire
(AVDL) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Avadel Pharmaceuticals Receives Unanimous Appeals Court Affirmation for LUMRYZ FDA Approval - Yahoo.co
Bullish Avadel Pharmaceuticals Insiders Loaded Up On US$761.7k Of Stock - Yahoo Finance
Avadel Pharmaceuticals plc (AVDL) Showcases LUMRYZ Success with 14 Abstracts, 4 Oral Presentations at SLEEP 2025 - MSN
How To Trade (AVDL) - news.stocktradersdaily.com
Avadel Shareholder Seeks Board Shakeup, Citing Millions Lost On LumryzAvadel Pharmaceuticals (NASDAQ:AVDL) - Benzinga
Institutional owners may take dramatic actions as Avadel Pharmaceuticals plc's (NASDAQ:AVDL) recent 7.2% drop adds to one-year losses - simplywall.st
Investor urges Avadel shareholders to vote against directors By Investing.com - Investing.com South Africa
ASL pushes for board shakeup at Avadel over handling of sleep drug rollout - MarketScreener
Avadel stock rises after appeals court upholds LUMRYZ approval - Investing.com
Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation - The Manila Times
Avadel Pharmaceuticals faces board challenge from investor ASL Strategic Valuereport By Investing.com - Investing.com UK
Avadel Pharmaceuticals Wins Appeal on LUMRYZ Approval, Reaffirming FDA Approval of the Drug. - AInvest
Form DEFA14A AVADEL PHARMACEUTICALS - StreetInsider
Wall Street Analysts See an 81.61% Upside in Avadel (AVDL): Can the Stock Really Move This High? - Yahoo Finance
1.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):